Search Results - "Weatherly, Jacqueline"

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications by Churi, Chaitanya R, Shroff, Rachna, Wang, Ying, Rashid, Asif, Kang, HyunSeon C, Weatherly, Jacqueline, Zuo, Mingxin, Zinner, Ralph, Hong, David, Meric-Bernstam, Funda, Janku, Filip, Crane, Christopher H, Mishra, Lopa, Vauthey, Jean-Nicholas, Wolff, Robert A, Mills, Gordon, Javle, Milind

“…Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing (NGS)…”
Get full text

Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis by Eckmann, Karen R, Patel, Dina K, Landgraf, Andrea, Slade, Julian H, Lin, E, Kaur, Harmeet, Loyer, Evelyne, Weatherly, Jacqueline M, Javle, Milind

“…Recent clinical trials for "biliary cancers" include a heterogenous group of patients with cholangiocarcinoma, gallbladder, and ampullary cancers. Limited data…”
Get full text

Tumor mutational burden (TMB) and co-existing actionable mutations in biliary tract cancers (BTC) by Jain, Apurva, Shroff, Rachna T., Zuo, Mingxin, Weatherly, Jacqueline, Meric-Bernstam, Funda, Isaacs, Randi, Ali, Siraj Mahamed, Bekaii-Saab, Tanios S., Javle, Milind M.

“…Abstract only 4086 Background: Mutations in DNA repair pathway were identified in 13% of Biliary Tract Cancers (BTC) [ Cancer2016;122:3838–3847]. High TMB…”
Get full text

An international collaborative design of clinical nursing practice guidelines for patients with cholangiocarcinoma by Acquisto, Susan, Iyer, Renuka V., Driskill, Karen M, Pinheiro, Natasha, Weatherly, Jacqueline, Musto, Kaitlyn R, Lowitzer, Heidi, McCallum, Lynne, Drapek, Lorraine

“…Abstract only 65 Background: Cholangiocarcinoma (CC) accounts for approximately 3% of all gastrointestinal cancers and have a poor incident to mortality rate…”
Get full text

Abstract 4491: Transforming growth factor (TGF) ≤ pathway and clinical outcome of pancreatic cancer by Javle, Milind M., Dong, Xiaoqun, Tan, Dongfeng, Li, Yanan, Kar, Siddhartha P., Baladandayuthapani, Veera, Weatherly, Jacqueline, Krishnan, Sunil, J, Tzu-chuan, Huang, Fogelman, David R., Abbruzzese, James L., Wolff, Robert A., Li, Donghui

“…Abstract Background: TGFβ acts both as a tumor suppressor or tumor promoter depending upon cellular context and stage of tumor progression. TGFβ exerts its…”
Get full text

Transforming growth factor (TGF) beta pathway and clinical outcome of pancreatic cancer by Javle, Milind M., Tan, Dongfeng, Li, Yanan, Kar, Siddhartha P., Baladandayuthapani, Veera, Dong, Xiaoqun, Weatherly, Jacqueline, Krishnan, Sunil, Huang, Tzu-chuan Jane, Fogelman, David R., Abbruzzese, James L., Wolff, Robert A., Li, Donghui

“…Abstract only 201 Background: TGF-beta acts both as a tumor suppressor or tumor promoter depending upon cellular context and stage of tumor progression. TGF-β…”
Get full text

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications: e115383 by Churi, Chaitanya R, Shroff, Rachna, Wang, Ying, Rashid, Asif, Kang, HyunSeon C, Weatherly, Jacqueline, Zuo, Mingxin, Zinner, Ralph, Hong, David, Meric-Bernstam, Funda

“…Background Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing…”
Get full text